Treatment with anti-toxoplasmic activity (TATA) for toxoplasma positive patients with bipolar disorders or schizophrenia: a cross-sectional study

Journal of Psychiatric Research
Guillaume FondNora Hamdani

Abstract

The association between Toxoplasma gondii seropositivity and respectively Bipolar Disorder (BD) and Schizophrenia/Schizoaffective disorder (SZ) is one of the most studied link between one pathogen and psychiatric disorders. The aim of the present study was thus to retrospectively determine if the administration of an antipsychotic and/or a mood stabilizer having known in vitro Anti-Toxoplasmic Activity (TATA+) was associated with a better clinical outcome in a population of 152 BD or 114 SZ patients and seropositive for T. gondii infection compared to patients receiving a treatment without anti-toxoplasmic activity (TATA-). This multicenter study was conducted in an academic public hospital during a 3-years period between 2009 and 2011. All consecutive inpatients and outpatients with SZ or BD diagnosis with a stable treatment for more than 4 weeks were recruited. socio-demographic and clinical characteristics measured with validated scales as well as a serological status for toxoplasmic infection were included. Treatments were classified according to their in vitro antitoxoplasmic activity. A multivariate model was used to determine the clinical characteristics that were significantly different between patients receiving a trea...Continue Reading

References

Apr 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·S A Montgomery, M Asberg
Nov 1, 1978·The British Journal of Psychiatry : the Journal of Mental Science·R C YoungD A Meyer
Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Mar 7, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R H YolkenI Rouslanova
Jan 22, 2002·Acta Tropica·Vern B Carruthers
Nov 19, 2004·Fundamental & Clinical Pharmacology·Eric DaillyMichel Bourin
Nov 7, 2006·Schizophrenia Bulletin·E Fuller TorreyRobert H Yolken
Aug 2, 2008·Microbes and Infection·Kami Kim, Louis M Weiss
Jun 24, 2009·Parasitology Research·Rodrigo Costa da Silva, Helio Langoni
Oct 5, 2010·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Flavie MathieuFrank Bellivier
Dec 8, 2010·Schizophrenia Bulletin·Alan S Brown, Paul H Patterson
Feb 26, 2011·The Journal of Parasitology·David G GoodwinDavid S Lindsay
Sep 6, 2011·Schizophrenia Research·Olaoluwa OkusagaTeodor T Postolache
Oct 1, 2011·PloS One·Emese PrandovszkyGlenn A McConkey
Nov 23, 2011·Schizophrenia Research·Isabel AriasJose Gutierrez
Dec 21, 2011·Clinical Schizophrenia & Related Psychoses·E Fuller Torrey, John M Davis
Mar 27, 2012·Schizophrenia Bulletin·E Fuller TorreyRobert H Yolken
Apr 4, 2012·International Journal of Environmental Research and Public Health·Jong-Min WooTeodor T Postolache
Oct 2, 2012·Schizophrenia Research·Fernanda Santos NascimentoCláudio Lúcio Rossi
Jan 1, 2013·Journal of Affective Disorders·Nora HamdaniMarion Leboyer
Aug 12, 2014·PloS One·Stéphane JamainMarion Leboyer

❮ Previous
Next ❯

Citations

Dec 18, 2015·Journal of Affective Disorders·G FondUNKNOWN FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group
Oct 21, 2015·Parasitology Research·Erika N Franco-HernandezJorge Enrique Gómez-Marín
Aug 31, 2016·Psychiatry Research·Awatef EsshiliBesma Bel Hadj Jrad
Sep 3, 2016·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Guillaume FondLaurent Boyer
Oct 30, 2016·BMC Medicine·Marion LeboyerLaurent Groc
Jan 12, 2017·Pathogens·Claudia Del GrandeFabrizio Bruschi
Mar 31, 2017·International Journal of Molecular Sciences·Matea Nikolac PerkovicNela Pivac
Nov 12, 2017·European Archives of Psychiatry and Clinical Neuroscience·G FondUNKNOWN FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) group
Apr 28, 2016·Current Opinion in Infectious Diseases·Hany M Elsheikha, Xing-Quan Zhu
Sep 24, 2020·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Santiago M FernandesÂngela Miranda-Scippa
May 17, 2017·Parasitology Research·Sam D Chorlton
Jul 1, 2019·European Psychiatry : the Journal of the Association of European Psychiatrists·Andrea MurruEduard Vieta
Oct 4, 2019·Tropical Parasitology·Abhijit Chaudhury, B V Ramana
Nov 27, 2018·Neuroscience and Biobehavioral Reviews·Shiraz TyebjiChristopher J Tonkin
Jun 29, 2021·Frontiers in Psychiatry·Teodor T PostolacheLisa A Brenner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Related Papers

European Archives of Psychiatry and Clinical Neuroscience
Guillaume FondJean-Francois Dubremetz
Journal of Clinical Psychopharmacology
Kamini VasudevRichard Hamish McAllister-Williams
Neuropsychiatric Disease and Treatment
Thawatchai LeelahanajThai Bipolar Registry Study Group
© 2021 Meta ULC. All rights reserved